Sherlock Biosciences appoints new chief commercial officer
Sherlock Biosciences announced today that it appointed Julie Garlikov as its first chief commercial officer.
Source: massdevice.com
📰 Bryan Dechairo News
Page 2 - Bryan Dechairo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bryan Dechairo. Real-time updates on events, politics, business and more.
Sherlock Bio raises $80 million to develop CRISPR-based diagnostics
By Bhanvi Satija and Manas Mishra (Reuters) - Sherlock Biosciences said on Tuesday it had raised $80 million in new funding to help bolster sales of i...
Source: whbl.com
Sherlock Biosciences Raises $80 Million in Series B Financing to Democratize At-Home Diagnostic Testing
/PRNewswire/ -- Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced it has raised...
United States Bryan Dechairo Paul Meister Sherlock Biosciences Novalis Lifesciences Prnewswire Sherlock Biosciences
Source: prnewswire.com
Sherlock Biosciences Raises $80 Million in Series B Financing to Democratize At-Home Diagnostic Testing
/PRNewswire/ -- Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced it has raised...
United States Bryan Dechairo Paul Meister Sherlock Biosciences Novalis Lifesciences Prnewswire Sherlock Biosciences
Source: prnewswire.com
Sherlock Bio raises $80 mln to develop CRISPR-based diagnostics
Sherlock Biosciences said on Tuesday it had raised $80 million in new funding to help bolster sales of its CRISPR-based COVID-19 test and develop new…
Source: financialpost.com
Sherlock Biosciences raises $80M Series B for at-home diagnostics
Sherlock Biosciences announced today that it raised $80 million in a Series B financing round to support its next-generation diagnostics.
Bryan Dechairo Sherlock Biosciences Novalis Lifesciences Illumina Ventures Albany Capital Catalio Capital Management
Source: massdevice.com
Sherlock Biosciences secures $80M to bring molecular diagnostics to the home
Diagnostics developer Sherlock Biosciences has advanced its molecular diagnostic capabilities, which can now produce faster results on low-cost devices. The startup will use its Series B round of funding to expand the reach of its technology, potentially placing it directly in the hands of consumers around the world.
United Kingdom Bryan Dechairo Sherlock Biosciences Novalis Lifesciences Broad Institute Harvard Wyss Institute For Biologically Inspired Engineering
Source: medcitynews.com
Sherlock Biosciences Raises $80M in Series B Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
United States Bryan Dechairo Paul Meister Sherlock Biosciences Novalis Lifesciences Illumina Ventures
Source: finsmes.com